Cardinal Health, Inc. CAH

220.22 (2.40) (1.08%) as of 25 Sep
Market cap
$51.6B
P/E
30.3×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Cardinal Health, Inc. (CAH) EV/EBITDA

As of 25 September 2026, Cardinal Health, Inc. (CAH) trades at a EV/EBITDA of 15.7×. Over the past ten years it has ranged from 0.0× (December 2022) to 241× (September 2022); the current reading is higher than 74% of that period. That is in line with the Medical Distribution industry median of 15.5× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2026 16.8× 14.33%
FY2025 14.7× 20.30%
FY2024 12.2× (30.15%)
FY2023 17.5× (90.19%)
FY2022 179× 1,049.52%
FY2021 15.5× —
FY2020 0.0× —
FY2019 6.5× (66.95%)
FY2018 19.5× 96.52%
FY2017 9.9× 7.46%

Quarterly

Period EV/EBITDA Change
Jun 2026 16.8× (0.27%)
Mar 2026 16.9× 5.35%
Dec 2025 16.0× 23.32%
Sep 2025 13.0× (11.76%)
42 more quarters

Against its own ten years

Low 0.0× High 241×
Ten-year median 12.3×
Current reading's percentile 74

EV/EBITDA against peers

Company EV/EBITDA
COSM Cosmos Health Inc. compare n/m
FOCL FocalTherics compare n/m
AHG Akso Health Group Sponsored ADR compare n/m
YI 111, Inc. Sponsored ADR compare n/m
ACH Accendra Health, Inc. compare 8.2×
HSIC Henry Schein, Inc. compare 12.0×
MCK McKesson Corporation compare 15.5×
CAH Cardinal Health, Inc. 15.7×
COR Cencora, Inc. compare 16.6×
Medical Distribution industry median 15.5×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on CAH